Psoriasis Therapeutics Market 2016 to grow at a CAGR of 9.95% during the period to 2020

Psoriasis is a common immune-mediated disease of the skin. In psoriasis, the skin grows fast and causes buildup of thick white, red, or silvery patches of skin. It alters the normal cell cycle of the skin. The new cells of the skin grow and move quickly to the surface of the skin to form patches known as "plaques". The plaques are commonly found on knees, elbows, scalp, hands, and feet. Psoriasis occurs mostly in adults, but can also be seen in children and adolescents. The etiology of the disease is unknown, however, it is believed to be an immune-mediated process. It is believed that the over-activity of the immune system can cause inflammation, thereby resulting in flaking of the skin.

Global Psoriasis Therapeutics market to grow at a CAGR of 9.95% over the period 2014-2019.

Covered in this Report

This report covers the present scenario and the growth prospects of the Global Psoriasis Therapeutics market for the period 2015-2019. To calculate the market size, the report considers revenue generated from the sales of various drugs including systemic and topical drugs used in the treatment of:

Psoriasis
Psoriatic Arthritis

Request For Free Report Sample @ http://goo.gl/pmMWBF

The Global Psoriasis Therapeutics market is segmented based on the mechanism of action of the drugs used to treat psoriasis and psoriatic arthritis as illustrated below:

TNF Inhibitors
PDE4 Inhibitors
Interleukin Blockers
Others

The Global Psoriasis Therapeutics market is also segmented based on the type of molecule used for the treatment of psoriasis, as illustrated below:

Biologics
Small Molecules

On the basis of route of administration adopted for the treatment of psoriasis, the Global Psoriasis Therapeutics market is segmented as follows:

Oral
Parenteral
Topical

Enquiry About This Report @ http://goo.gl/1Uhyaf

The report also presents the vendor landscape and a corresponding detailed analysis of the top four vendors in the Global Psoriasis Therapeutics market. The vendor landscape section includes a market share analysis of the major vendors along with the competitive performances of their product portfolios. In addition, it discusses the major drivers that influence the growth of the market. It also outlines the challenges faced by the vendors and the market at large, as well as the key trends that are emerging in the market. In addition, late-stage pipeline molecules developed for the treatment of psoriasis have been discussed.

Global Psoriasis Therapeutics Market 2015-2019, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the Americas, the APAC and the EMEA regions; it also covers the Global Psoriasis Therapeutics market landscape and its growth prospects in the coming years. The report also includes a discussion of the key vendors operating in this market.

Key Regions

Americas
APAC
EMEA

Read More Research with TOC @ http://goo.gl/PgknW9

Key Vendors

Abbvie
Amgen
Janssen Pharmaceuticals
Pfizer

Other Prominent Vendors

AbGenomics
Almirall
Anacor Pharmaceuticals
ApoPharma
Astellas Pharma
AstraZeneca
Aurinia Pharmaceuticals
Biocon
Biogen Idec
Biotest
Boehringer Ingelheim
Bristol-Myers Squibb

About Us:

At Global Market Firm, we have market research reports from competent publishers. Our Research Specialists have thorough knowledge about offerings from different publishers and different reports on respective industries. They will help you refine search parameters and get desired results at your doorstep. Here you can review the complete range of available reports, review the scope of study and methodology of reports.

Contact US:

Joel John
Suite #8138, 3422 SW 15 Street,
Deerfield Beach, Florida 33442
United States
Toll Free: +1-855-465-4651 (USA-CANADA)
Tel: +1-386-310-3803
Website: http://www.globalmarketfirm.com/
Email: erik@globalmarketfirm.com

This release was published on openPR.